Jun Chen

Dr. Jun Chen

orcid

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2015 in Immunity
Verified
Journal Article
Closed access
RHReiko Horai
Reiko Horai
CZCarlos R. Zárate-Bladés
Carlos R. Zárate-Bladés
PDPatricia Dillenburg-Pilla
Patricia Dillenburg-Pilla
JCJun Chen
Jun Chen
JKJennifer L. Kielczewski
Jennifer L. Kielczewski
RCRachel R. Caspi
Rachel R. Caspi

1 February 2010 in Journal of Virology
Verified
Journal Article
Closed access
JCJun Chen
Jun Chen
YLYuk Fai Lau
Yuk Fai Lau
ELElaine W. Lamirande
Elaine W. Lamirande
CPChristopher D. Paddock
Christopher D. Paddock
JBJeanine H. Bartlett
Jeanine H. Bartlett
KSKanta Subbarao
Kanta Subbarao
We characterized the cellular immune response to severe acute respiratory syndrome coronavirus (SARS-CoV) infection in 12- to 14-month-old BALB/c mice, a model that mimics features of the human disease. Following intranasal administration, the virus replicated in the lungs, with peak titers on day 2 postinfection. Enhanced production of cytokines (tumor necrosis factor alpha [TNF-α] and interleukin-6 [IL-6]) and chemokines (CXCL10, CCL2, CCL3, and CCL5) correlated with migration of NK cells, macrophages, and plasmacytoid dendritic cells (pDC) into the lungs. By day 7, histopathologic evidence of pneumonitis was seen in the lungs when viral clearance occurred. At this time, a second wave of enhanced production of cytokines (TNF-α, IL-6, gamma interferon [IFN-γ], IL-2, and IL-5), chemokines (CXCL9, CXCL10, CCL2, CCL3, and CCL5), and receptors (CXCR3, CCR2, and CCR5), was detected in the lungs, associated with an influx of T lymphocytes. Depletion of CD8+T cells at the time of infection did not affect viral replication or clearance. However, depletion of CD4+T cells resulted in an enhanced immune-mediated interstitial pneumonitis and delayed clearance of SARS-CoV from the lungs, which was associated with reduced neutralizing antibody and cytokine production and reduced pulmonary recruitment of lymphocytes. Innate defense mechanisms are able to control SARS-CoV infection in the absence of CD4+and CD8+T cells and antibodies. Our findings provide new insights into the pathogenesis of SARS, demonstrating the important role of CD4+but not CD8+T cells in primary SARS-CoV infection in this model.

1 April 2007 in Annual Review of Immunology
Verified
Journal Article
Closed access
JCJun Chen
Jun Chen
KSKanta Subbarao
Kanta Subbarao
Severe acute respiratory syndrome (SARS) presented as an atypical pneumonia that progressed to acute respiratory distress syndrome in ∼20% of cases and was associated with a mortality of about 10%. The etiological agent was a novel coronavirus (CoV). Angiotensin-converting enzyme 2 is the functional receptor for SARS-CoV; DC-SIGN and CD209L (L-SIGN) can enhance viral entry. Although the virus infects the lungs, gastrointestinal tract, liver, and kidneys, the disease is limited to the lungs, where diffuse alveolar damage is accompanied by a disproportionately sparse inflammatory infiltrate. Pro-inflammatory cytokines and chemokines, particularly IP-10, IL-8, and MCP-1, are elevated in the lungs and peripheral blood, but there is an unusual lack of an antiviral interferon (IFN) response. The virus is susceptible to exogenous type I IFN but suppresses the induction of IFN. Innate immunity is important for viral clearance in the mouse model. Virus-specific neutralizing antibodies that develop during convalescence prevent reinfection in animal models.

1 August 2020 in Immunity
Verified
Journal Article
Closed access
WCWai Po Chong
Wai Po Chong
MMMary J. Mattapallil
Mary J. Mattapallil
KRKumarkrishna Raychaudhuri
Kumarkrishna Raychaudhuri
SBSo Jin Bing
So Jin Bing
SWSihan Wu
Sihan Wu
RCRachel R. Caspi
Rachel R. Caspi

8 April 2010 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
MFMatthew B. Frieman
Matthew B. Frieman
JCJun Chen
Jun Chen
TMThomas E. Morrison
Thomas E. Morrison
AWAlan Whitmore
Alan Whitmore
WFWilliam Funkhouser
William Funkhouser
RBRalph S. Baric
Ralph S. Baric
Severe acute respiratory syndrome coronavirus (SARS-CoV) infection often caused severe end stage lung disease and organizing phase diffuse alveolar damage, especially in the elderly. The virus-host interactions that governed development of these acute end stage lung diseases and death are unknown. To address this question, we evaluated the role of innate immune signaling in protection from human (Urbani) and a recombinant mouse adapted SARS-CoV, designated rMA15. In contrast to most models of viral pathogenesis, infection of type I, type II or type III interferon knockout mice (129 background) with either Urbani or MA15 viruses resulted in clinical disease outcomes, including transient weight loss, denuding bronchiolitis and alveolar inflammation and recovery, identical to that seen in infection of wildtype mice. This suggests that type I, II and III interferon signaling play minor roles in regulating SARS pathogenesis in mouse models. In contrast, infection of STAT1−/− mice resulted in severe disease, high virus titer, extensive pulmonary lesions and 100% mortality by day 9 and 30 post-infection with rMA15 or Urbani viruses, respectively. Non-lethal in BALB/c mice, Urbani SARS-CoV infection in STAT1−/− mice caused disseminated infection involving the liver, spleen and other tissues after day 9. These findings demonstrated that SARS-CoV pathogenesis is regulated by a STAT1 dependent but type I, II and III interferon receptor independent, mechanism. In contrast to a well documented role in innate immunity, we propose that STAT1 also protects mice via its role as an antagonist of unrestrained cell proliferation. The SARS coronavirus is a highly pathogenic respiratory virus that caused the first epidemic of the 21st century. During the epidemic ∼10% of those infected died and the elderly were particularly vulnerable. Severe cases developed acute lung injury with pulmonary fibrosis and Acute Respiratory Distress Syndrome (ARDS). Little is known about the molecular mechanisms governing its virus pathogenesis and high lethality. Using a mouse model of infection with the epidemic strain of SARS-CoV (Urbani) as well as a recombinant mouse adapted strain of SARS-CoV (rMA15), we showed that a protein normally associated with the innate immune response, STAT1, plays an important role in the development of severe end stage lung injury. However, the lack of a normal innate immune type I, type II and type III interferon response did not enhance virus pathogenesis. Our work suggests that STAT1 may play a key role in development of acute lung injury and other chronic lung pathology, most likely by affecting cell proliferation and wound repair pathways.

1 August 2013 in Journal of Autoimmunity
Verified
Journal Article
Closed access
RHReiko Horai
Reiko Horai
PSPhyllis B. Silver
Phyllis B. Silver
JCJun Chen
Jun Chen
RARajeev K. Agarwal
Rajeev K. Agarwal
WCWai Po Chong
Wai Po Chong
RCRachel R. Caspi
Rachel R. Caspi